University of Tasmania
Browse

File(s) under permanent embargo

Incretin-based therapies

journal contribution
posted on 2023-05-21, 20:46 authored by Luke BereznickiLuke Bereznicki
The number of Australians with type 2 diabetes mellitus (T2DM) has tripled since 1981 and continues to increase. It is projected that 1.6 million Australians will have type 2 diabetes by 2030. Because T2DM frequently co-exists with excess weight, hypertension and dyslipidaemia, health professionals involved in the management of diabetes should focus on blood pressure management, cholesterol lowering and consider the use of lowdose aspirin for primary prevention (although this is now contentious) as means of reducing cardiovascular risk, in addition to targeting glycaemic control

History

Publication title

Australian Pharmacist

Volume

29

Issue

6

Pagination

508-513

ISSN

0728-4632

Department/School

School of Pharmacy and Pharmacology

Publisher

Pharmaceutical Society of Australia

Place of publication

Australia

Rights statement

Copyright © 2010 Pharmaceutical Society of Australia

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC